Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection
Numerous canonical cellular signaling pathways modulate hepatitis B virus (HBV) replication. HBV genome products are known to play a significant role in regulating these cellular pathways for the liver’s viral-related pathology and physiology and have been identified as the main factor in hepatocarc...
Main Authors: | Yan Yan, Yuanwang Qiu, Chantsalmaa Davgadorj, Chunfu Zheng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2022.847539/full |
Similar Items
-
Corrigendum: Novel molecular therapeutics targeting signaling pathway to control hepatitis B viral infection
by: Yan Yan, et al.
Published: (2023-07-01) -
Vitamin D Signaling in Inflammation and Cancer: Molecular Mechanisms and Therapeutic Implications
by: Ahmed El-Sharkawy, et al.
Published: (2020-07-01) -
Tight Junction Protein Signaling and Cancer Biology
by: Zeina Nehme, et al.
Published: (2023-01-01) -
Association between Notch signaling pathway and cancer
by: Nadežda Lachej, et al.
Published: (2013-01-01) -
Signaling pathways in macrophages: molecular mechanisms and therapeutic targets
by: Ming Li, et al.
Published: (2023-10-01)